Punit Dhillon

Insider Reports History

Entity
Individual
Location
5820 Nancy Ridge Drive, San Diego, CA
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Punit Dhillon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 330K $1.65M $4.99 Nov 18, 2024 Direct
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 9.34K $46.6K $4.99 Nov 15, 2024 Trust
Skye Bioscience, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 650K Oct 28, 2024 Direct
Arch Therapeutics, Inc. Director Stock Option (right to buy) 250K Nov 10, 2022 Direct

Insider Reports Filed by Punit Dhillon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SKYE Skye Bioscience, Inc. Nov 15, 2024 2 -$414K 4 Nov 19, 2024 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Oct 28, 2024 1 $0 4 Oct 30, 2024 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Aug 26, 2024 1 $0 4 Aug 27, 2024 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Feb 29, 2024 2 $0 4/A Mar 4, 2024 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Feb 29, 2024 2 $0 4 Mar 1, 2024 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Nov 6, 2023 2 $0 4 Nov 6, 2023 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Aug 25, 2023 5 $18.5K 4/A Aug 31, 2023 Chief Executive Officer, Director
SKYE Skye Bioscience, Inc. Nov 10, 2022 6 $0 4 Nov 15, 2022 Chief Executive Officer, Director
ARTH Arch Therapeutics, Inc. Nov 10, 2022 1 $0 4 Nov 10, 2022 Director
SKYE Skye Bioscience, Inc. Dec 14, 2021 2 $0 4 Dec 16, 2021 Chief Executive Officer, Director
ARTH Arch Therapeutics, Inc. Sep 27, 2021 2 $0 4 Oct 1, 2021 Director